|
A.A. Volkov, M.I. Petrichko, N.V. Budnik
Correction of erectile dysfunction in patients with BPH using daily administration of tadalafil 5 mg against the background of combined drug therapy
|
№5 / 2013
|
|
Rasner P.I., Pushkar D.Yu.
The evaluation of efficacy and safety of treatment with dalfaz SR in patients with prostatic adenoma
|
№3 / 2013
|
|
Kamalov A.A., Osmolovsky B.E., Okhobotov D.A., Khodyreva L.A., Takhirzade T.B., Tahirzade A.M., Gevorkyan A.R.
Combined treatment of patients with erectile dysfunction and disorders of urination
|
№3 / 2013
|
|
L.G. Spivak.
Efficacy and safety of use of likoprofit® in patients with chronic prostatitis and prostatic adenoma
|
№2 / 2013
|
|
A.A. Volkov, M.I. Petrichko, N.V. Budnik, A.R. Dukhin.
Tadalafil in patients with benign prostatic hyperplasia during conservative combined therapy
|
№2 / 2013
|
|
V.N. Pavlov, B.K. Komyakov, M.E. Grigoryev, A.V. Sivkov, B.I. Blyumberg, A.A. Kazikhinurov, A.A. Izmaylov, A.V. Boyarko, R. A. Abzalilov.
Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I–II prostatic adenoma
|
№2 / 2013
|
|
A.I. Neimark, B.A. Neimark, N.A. Nozdrachev
Vitaprost forte for the treatment of patients with benign prostate hyperplasia
|
№1 / 2013
|
|
Vasilchenko M.I., Shershnev S.P., Zelenin D.A., Zagarova V.I., Proletarsky A.V.
Experience in extraurethral transvesical adenomectomy patients with adenoma prostate gland
|
№6 / 2012
|
|
Grigoriev M.E.
Afala in the treatment of patients with BPH: efficacy and safety
|
№6 / 2012
|
Русский
